Human genetics of Buruli ulcer.


Journal

Human genetics
ISSN: 1432-1203
Titre abrégé: Hum Genet
Pays: Germany
ID NLM: 7613873

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 19 02 2020
accepted: 02 04 2020
pubmed: 9 4 2020
medline: 13 6 2020
entrez: 9 4 2020
Statut: ppublish

Résumé

Buruli ulcer, the third most common mycobacterial disease worldwide, is caused by Mycobacterium ulcerans and characterized by devastating necrotizing skin lesions. Susceptibility to Buruli ulcer is thought to depend on host genetics, but very few genetic studies have been performed. The identification of a microdeletion on chromosome 8 in a familial form of severe Buruli ulcer suggested a monogenic basis of susceptibility. The role of common host genetic variants in Buruli ulcer development has been investigated in only three candidate-gene studies targeting genes involved in mycobacterial diseases. A recent genome-wide association study suggested a probable role for long non-coding RNAs and strengthened the contribution of autophagy as a major defense mechanism against mycobacteria. In this review, we summarize the history, epidemiological and clinical aspects of Buruli ulcer, focusing particularly on genetic findings relating to susceptibility to this disease. Finally, we discuss exciting new genetic avenues arising, in particular, from studies of mouse models, and the need for different disciplines to work together, to benefit from the extensive work on other mycobacterial diseases, mostly tuberculosis and leprosy. We are convinced that such pooling of effort will lead to the development of efficient novel strategies for combatting Buruli ulcer.

Identifiants

pubmed: 32266523
doi: 10.1007/s00439-020-02163-1
pii: 10.1007/s00439-020-02163-1
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

847-853

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR 12 BSV3 0013 01
Organisme : Agence Nationale de la Recherche
ID : ANR 17 BSV3 0013 01
Organisme : Agence Nationale de la Recherche
ID : ANR-10-IAHU-01
Organisme : Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"
ID : ANR-10-LABX-62-IBEID

Auteurs

Jeremy Manry (J)

Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Paris, France. jeremy.manry@inserm.fr.
Laboratory of Human Genetics of Infectious Diseases, Imagine Institute, INSERM U1163, Université de Paris, 75015, Paris, France. jeremy.manry@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH